SEC Form 8-K: Press Release dated November 15, 2023

BPTH_Form_8-K_Q3_Earnings_Release

SEC Form 10-Q for Period ending September 30, 2023

BPTH_Form_10-Q_Q3_2023

BIO-PATH HOLDINGS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS

BPTH_Third_Quarter_2023_Earnings_Release

Webcast Link to Third Quarter 2023 Financial Results Conference Call on Wednesday, November 15, 2023 at 8:30 a.m. ET

Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023

BPTH_Third_Quarter2023_Earnings_Announcement

SEC Form 8-K: Press Release dated October 24, 2023

BPTH_Form_8-K_PR_10-24-2023

Webcast Link to Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia – October 30, 2023 at 9:00 a.m. ET

Bio-Path Holdings to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia

BPTH_KOL_Event_Announcement

SEC Form 8-K: Nasdaq Notice of Noncompliance

BPTH_Form-8-K_Nasdaq_Notice_of_Noncompliance

Webcast Link to H.C. Wainwright 25th Annual Global Investment Conference – Tuesday. September 12, 2023